These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 28320034)

  • 1. Variations in Infant CYP2B6 Genotype Associated with the Need for Pharmacological Treatment for Neonatal Abstinence Syndrome in Infants of Methadone-Maintained Opioid-Dependent Mothers.
    Mactier H; McLaughlin P; Gillis C; Osselton MD
    Am J Perinatol; 2017 Jul; 34(9):918-921. PubMed ID: 28320034
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased DNA Methylation of ABCB1, CYP2D6, and OPRM1 Genes in Newborn Infants of Methadone-Maintained Opioid-Dependent Mothers.
    McLaughlin P; Mactier H; Gillis C; Hickish T; Parker A; Liang WJ; Osselton MD
    J Pediatr; 2017 Nov; 190():180-184.e1. PubMed ID: 28867064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal abstinence syndrome: treatment and pediatric outcomes.
    Logan BA; Brown MS; Hayes MJ
    Clin Obstet Gynecol; 2013 Mar; 56(1):186-92. PubMed ID: 23314720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Could prenatal food insecurity influence neonatal abstinence syndrome severity?
    Rose-Jacobs R; Trevino-Talbot M; Lloyd-Travaglini C; Cabral HJ; Vibbert M; Saia K; Wachman EM
    Addiction; 2019 Feb; 114(2):337-343. PubMed ID: 30422365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal opioid toxicity: opioid withdrawal (abstinence) syndrome with emphasis on pharmacogenomics and respiratory depression.
    Baldo BA
    Arch Toxicol; 2023 Oct; 97(10):2575-2585. PubMed ID: 37537419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication.
    Kaltenbach K; Holbrook AM; Coyle MG; Heil SH; Salisbury AL; Stine SM; Martin PR; Jones HE
    Addiction; 2012 Nov; 107 Suppl 1(0 1):45-52. PubMed ID: 23106926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective, observational study on medication for opioid use disorder during pregnancy and risk for neonatal abstinence syndrome.
    Sujan A; Cleary E; Douglas E; Aujla R; Boyars L; Smith C; Guille C
    Fam Pract; 2022 Mar; 39(2):311-315. PubMed ID: 34537839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antenatal methadone vs buprenorphine exposure and length of hospital stay in infants admitted to the intensive care unit with neonatal abstinence syndrome.
    Tolia VN; Murthy K; Bennett MM; Miller ES; Benjamin DK; Smith PB; Clark RH
    J Perinatol; 2018 Jan; 38(1):75-79. PubMed ID: 29048415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal Substance Use and Neonatal Abstinence Syndrome: A Descriptive Study.
    McQueen KA; Murphy-Oikonen J; Desaulniers L
    Matern Child Health J; 2015 Aug; 19(8):1756-65. PubMed ID: 25656717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison.
    Unger A; Jagsch R; Jones H; Arria A; Leitich H; Rohrmeister K; Aschauer C; Winklbaur B; Bäwert A; Fischer G
    Addiction; 2011 Jul; 106(7):1355-62. PubMed ID: 21438938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
    Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
    Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study.
    Bakstad B; Sarfi M; Welle-Strand GK; Ravndal E
    Eur Addict Res; 2009; 15(3):128-34. PubMed ID: 19332991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of prenatal alcohol co-exposure on neonatal abstinence syndrome in infants born to mothers in opioid maintenance treatment.
    Kreitinger C; Gutierrez H; Hamidovic A; Schmitt C; Sarangarm P; Rayburn WF; Leeman L; Bakhireva LN
    J Matern Fetal Neonatal Med; 2016 Mar; 29(5):783-8. PubMed ID: 25758627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates.
    Gaalema DE; Scott TL; Heil SH; Coyle MG; Kaltenbach K; Badger GJ; Arria AM; Stine SM; Martin PR; Jones HE
    Addiction; 2012 Nov; 107 Suppl 1(0 1):53-62. PubMed ID: 23106927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obstetrical and neonatal outcomes of methadone-maintained pregnant women: a canadian multisite cohort study.
    Ordean A; Kahan M; Graves L; Abrahams R; Kim T
    J Obstet Gynaecol Can; 2015 Mar; 37(3):252-257. PubMed ID: 26001872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Outcomes of Infants with Neonatal Abstinence Syndrome.
    Maguire DJ; Taylor S; Armstrong K; Shaffer-Hudkins E; Germain AM; Brooks SS; Cline GJ; Clark L
    Neonatal Netw; 2016; 35(5):277-86. PubMed ID: 27636691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy.
    O'Connor AB; Collett A; Alto WA; O'Brien LM
    J Midwifery Womens Health; 2013; 58(4):383-8. PubMed ID: 23931660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between intrapartum fetal heart rate patterns and neonatal abstinence syndrome in methadone exposed neonates.
    Leeman LM; Brown SA; Albright B; Skipper B; Hsi A; Rayburn WF
    J Matern Fetal Neonatal Med; 2011 Jul; 24(7):955-9. PubMed ID: 21142769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perinatal risk factors for the neonatal abstinence syndrome in infants born to women on methadone maintenance therapy.
    Liu AJ; Jones MP; Murray H; Cook CM; Nanan R
    Aust N Z J Obstet Gynaecol; 2010 Jun; 50(3):253-8. PubMed ID: 20618243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal vagal tone change in response to methadone is associated with neonatal abstinence syndrome severity in exposed neonates.
    Jansson LM; Dipietro JA; Elko A; Velez M
    J Matern Fetal Neonatal Med; 2007 Sep; 20(9):677-85. PubMed ID: 17701668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.